Cara Therapeutics | CARA - Custo de Mercadoria Vendida





Custo de Mercadoria Vendida Alterar Data
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 3.96M 1.16M 2025-09
Chugai Pharma JPY 104.22B 11.43B 2026-06
Cipla INR 29.71B 3.4B 2026-06
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 1.82M 1.71M 2026-03
CSL USD 3.87B 2.08B 2025-12
Grifols EUR 1.51B 184.45M 2025-12
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
J&J USD 8B 67M 2026-06
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
RedHill Biopharma USD 702K 0 2024-06
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12